9
Views
13
CrossRef citations to date
0
Altmetric
Articles

Antimicrobial Treatment of Periodontal Diseases Disturbs the Human Ecology: a Review

Pages 331-342 | Published online: 18 Jul 2013

REFERENCES

  • Listgarten MA. Nature of periodontal diseases: Pathogenic mechanisms. J Periodontol Res 1987; 22: 172–8.
  • Quintiliani Jr R, Courvalin P. Mechanisms of resistance to antimicrobial agents. In: Murray PR, Baron EJ, Pfaller MA, Tenover FC, Yolken RH, eds. Manual of clinical microbiolo-gy. Washington DC: ASM Press, 1995;1308–26.
  • Seppälä H, Nissinen A, Jarvinen H et al. Resistance to erythromycin in group A streptococci. N Engl J Med 1992; 326: 292–7.
  • Finegold SM. Anaerobic infections in humans. Anaerobe 1995; 1: 3–9.
  • Rams TE, Slots J. Antibiotics in periodontal therapy: an update. Compend Contin Educ Dent (Article 3) 1992; 12: 1130–45.
  • Slots J, Rams TE. Antibiotics in periodontal therapy: advantages and disadvantages. J Clin Periodontol 1990; 17: 479–93.
  • Listgarten MA. Microbial composition and pattern of antibiotic resistance in subgingival microbial samples from patients with refractory periodontitis. J Periodontol 1993; 64: 155–61.
  • Rams TE, Feik D, Young V, et al. Enterococci in human periodontitis. Oral Microbiol Immunol 1992; 7: 249–52.
  • Rams TE, BabaIola 00, Slots J. Subgingival occurrence of enteric rods, yeasts and staphylococci after systemic doxy-cycline therapy. Oral Microbiol Immunol 1990; 5: 166–8.
  • Gjermo P. Contemporary use of agents in the control of progressive periodontitis. Int Dent J 1993; 43: 499–505.
  • Walker C, Gordon J. The effect of dindamycin on the microbiota associated with refractory periodontitis. J Periodontol 1990; 61: 692–8.
  • Nord CE, Heimdahl A, Kager L. Antimicrobial induced alterations of the human oropharyngeal and intesti-nal microflora. Scand J Infect Dis 1986; 49: 64–72.
  • Edlund C, Nord CE. Ecological impact of antimicrobial agents on human intestinal microflora. Alpe Adria Microbiol J 1993; 3: 137–64.
  • Hawkey PM. Resistant bacteria in the normal human flora. J Antimicrob Chemother 1986; 18: 133–9.
  • Hupp JR. Changing methods of preventing infective endocarditis following dental procedures: 1943 to 1993. J Oral Maxiofac Surg 1993; 51: 616-623.17.
  • Bergan T. Pharmacokinetic differentiation and conse-quences for normal microflora. Scand J Infect Dis 1986; 49: 91–9.
  • Heimdahl A, Nord CE. Effect of phenoxymethylpeni-cillin and dindamycin on the oral, throat and faecal microflo-ra of man. Scand J Infect Dis 1979; 11: 233–42.
  • Heimdahl A, Nord CE. Influence of doxycycline on the normal human flora and colonization of the oral cavity and colon. Scand J Infect Dis 1983; 15: 293–302.
  • Heimdahl A, Nord CE. Effect of tinidazole on the oral, throat and colon microflora of man. Med Microbiol Immunol 1980; 168: 1–10.
  • Bergan T, Delin C, Johansen S et al. Pharmacokinetics of ciprofloxacin and effect of repeated dosage on salivary and fecal microflora. Antimicrob Agents Chemother 1986; 29: 298–302.
  • Kling PA, Qstensson R, Granström S, Burman LG. A 7-year survey of drug resistance in aerobic and anaerobic fecal bacteria of surgical inpatients: clinical relevance and relation to local antibiotic consumption. Scand J Infect Dis 1989; 21: 589–96.
  • Levy SB, Marshall B, Schluederberg S, Rowse D, Davies J. High frequency of antimicrobial resistance in human fecal flora. Antimicrob Agents Chemother 1988; 32: 1801–6.
  • London N, Nijsten R, Mertens P, v. d. Bogaard A, Stobberingh E. Effect of antibiotic therapy on the antibiotic resistance of faecal Escherichia coli in patients attending gen-eral practitioners. J Antimicrob Chemother 1994; 34: 239–46.
  • Stark C, Edlund C, Sjöstedt S, Kristensen G, Nord CE. Antimicrobial resistance in human oral and intestinal anaero-bic microfloras. Antimicrob Agents Chemother 1993; 37: 1665–9.
  • Shanahan PMA, Thomson CJ, Amyes SGB. Beta-lactam resistance in aerobic faecal flora from general practice patients in the UK. Eur J Chin Microbiol Infect Dis 1994; 13: 760–3.
  • Brismar B, Edlund C, Nord CE. Impact of cefpo-doxime proxetil and amoxicillin on the normal oral and intestinal microflora. Eur J Chin Microbiol Infect Dis 1993; 12: 714–20.
  • Simon C, Stile W, Wilkinson PJ. Skin infections. In: Simon C, Stile W, Wilkinson PJ. eds. Antibiotic therapy in clinical practice. Stuttgart-New York: Schattauer Verlag, 1985; 425–32.
  • Abu-Fanas SH, Drucker DB, Hull PS, et al. Identification, and susceptibility to seven antimicrobial agents, of 61 Gram-negative anaerobic rods from periodontal packets. J Dent 1991; 19: 46–50.
  • Nagy E, Szóke I, Gacs M, et al. Resistance to beta-lac-tam antibiotics and beta-lactamase production of Bacteroides, Porphyromonas and Prevotella strains. Acta Microbiol Immunol Hungerica 1995; 43: 287–99.
  • Yao JDC, Moellering RC Jr. Antimicrobial agents. In: Murray PR, Baron EJ, Pfaller MA, Tenover FC, Yolken RH, eds. Manual of clinical microbiology. Washington DC: ASM Press, 1995: 1281–1307.
  • Goodson JM, Tanner A. Antibiotic resistance of the subgingival microbiota following local tetracycline therapy. Oral Microbiol Immunol 1992; 7: 113–7.
  • Fazakerley MW, Mc Gowan P, Hardy P et al. A com-parative study of cephradine, amoxycillin and phenoxy-methylpenicillin in the treatment of acute dentoalveolar infec-tion. Br Dent J 1993; 174: 359–63.
  • Reig M, Baquero F. Antibacterial activity of davulanate and tazobactam on Peptostreptococcus spp. J Antimicrob Chemother 1994; 33: 358–9.
  • Tunér K, Nord CE. Characterization of a new beta-lac-tamase from Fusobacterium nucleatum by substrate profiles and chromatofocusing patterns. J Antimicrob Chemother 1985; 16: 23–30.
  • Aronoff SC, Jacobs MR, Johenning S et al. Comparative activities of the beta-lactamase inhibitors YTR 830, sodium clavulanate, and sulbactam combined with amoxicillin or ampicillin. Antimicrob Agents Chemother 1984; 26: 580–2.
  • Hillier SH, Moncla BJ. Peptostreptococcus, Propionibacterium, Eubacterium, and other nonsporeforming anaerobic Gram-positive bacteria. In: Murray PR, Baron EJ, Pfaller MA, Tenover FC, Yolken RH, eds. Manual of clinical microbiology. Washington DC: ASM Press, 1995: 587–602.
  • Jousimies HR, Summanen PH, Finegold SM. Bacteroides, Porphyromonas, Prevotella, Fusobacterium, and other anaerobic Gram-negative bacteria. In: Murray PR, Baron EJ, Pfaller MA, Tenover FC, Yolken RH, eds. Manual of clinical microbiology. Washington DC: ASM Press, 1995: 603–20.
  • Wexler HM, Molitoris E, Finegold SM. In vitro activi-ties of three of the newer quinolones against anaerobic bacte-ria. Antimicrob Agents Chemother 1992; 36: 239–43.
  • Walker CB, Gordon JM, Magnusson I, Clark VC/B. A role for antibiotics in the treatment of refractory periodonti-tis. J Periodontol 1993; 64: 772–81.
  • Pavicic MJAMP, van Winkelhof AJ, de Graaff J. In vitro susceptibilities of Actinobacillus actinomycetemcomitans to a number of antimicrobial combinations. Antimicrob Agents Chemother 1992; 36: 2634–8.
  • Magnusson I, Low SB, McArthur WP, et al. Treatment of subjects with refractory periodontal disease. J Clin Periodontol 1994; 21: 628–37.
  • Haffajee AD, Dilbart S, Kent RU J et al. Clinical and microbiological changes associated with the use of 4 adjunc-tive systemically administered agents in the treatment of peri-odontal infections. J Clin Periodontol 1995; 22: 618–27.
  • Asikainen S, Jousimies-Somer H, Kanervo A et al. The immediate efficacy of adjunctive doxycycline in treatment of localized juvenile periodontitis. Arch Oral Biol 1990; 35: 231–4.
  • Saxén L, Asikainen S, Kanervo A et al. The long-term efficacy of systemic doxycycline medication in the treatment of localized juvenile periodontitis. Arch Oral Biol 1990; 35: 227–9.
  • Olsvik B, Tenover FC. Tetracycline resistance in peri-odontal pathogens. Clin Infect Dis 1993; 16: 310–3.
  • Fiehn NE, Westergaard J. Recurrent periodontitis: effect of doxycycline on the subgingival microflora. 2 years observations. J Dent Res 1991; 70: 836.
  • McCulloch CAG, Birek P, Overall C, et al. Randomized controlled trial of doxycycline in prevention of recurrent periodontitis in high-risk patients: antimicrobial activity and collagenase inhibition. J Clin Periodontol 1990; 17: 616–22.
  • van Winkelhoff AJ, Tijhof CJ, deGraaff J. Microbiological and clinical results of metronidazole plus amoxycillin therapy in Actinobacillus actinomycetemcomitans-associated periodontitis. J Periodontol 1992; 63: 52–7.
  • Nagy E, Földes J. Inactivation of metronidazole by Enterococcus faecalis. J Antimicrob Chemother 1991; 27: 63–70.
  • Söder PO, Frithiof L, Wikner S, et al. The effect of sys-temic metronidazole after non-surgical treatment in moderate and advanced periodontitis in young adults. J Periodontol 1990; 61: 281–8.
  • Loesche WJ, Giordano JR, Hujoel P, et al. Metronidazole in periodontitis: reduced need for surgery. J Clin Periodontol 1992; 19: 103–12.
  • Slots J, Feik D, Rams TE. Prevalence and antimicrobial susceptibility of Enterobacteriaceae, Pseudomonadaceae and Acinetobacter in human periodontitis. Oral Microbiol Immunol 1990; 5: 149–54.
  • Aldridge KE. The occurrence, virulence and antimicro-bial resistance of anaerobes in polymicrobial infections. Am J Surg 1995; 169: 2–7.
  • Marsh PD. The significance of maintaining the stability of the natural microflora of the mouth. Br Dent J 1991; 174–7.
  • Rams TE, Feik D, Slots J. Ciprofloxacin/metronidazole treatment of recurrent adult periodontitis. J Dent Res 1992; 71: 319.
  • Tonetti MS, Giovanpaolo PP, Cortellini P. Principles and clinical applications of periodontal controlled drug deliv-ery with tetracycline fibers. Int J Periodont & Rest Dent 1994; 14: 421–35.
  • Roskos KV, Fritzinger BK, Rao SS, et al. Development of a drug delivery system for the treatment of periodontal dis-ease based on bioerodible poly(orto esters). Biomathematics 1995; 16: 313–7.
  • Tonetti M, Mombelli A, Lehmann B et al. Impact of oral ecology on the recolonization of locally treated periodon-tal pockets. J Dent Res 1995; 74: 481.
  • Newman M, Komman K, Doherty F. A 6-month multi-center evaluation of adjunctive tetracycline fiber therapy used in conjunction with scaling and root planing in maintenance patients: clinical results. J Periodontol 1994; 65: 685–91.
  • Minabe M, Takeuchi K, Nishimura T et al. Therapeutic effects of combined treatment using tetracycline-immobilized collagen film and root planing in periodontal furcation defects. J Clin Periodontol 1991; 18: 287–90.
  • Larsen T. Occurrence of doxycycline resistant bacteria in the oral cavity after local administration of doxycycline in patients with periodontal disease. Scand J Infect Dis 1991; 23: 89–95.
  • Wade WG, Moran J, Morgan JR, et al. The effect of antimicrobial acrylic strips on the subgingival microflora in chronic periodontitis. J Clin Periodontol 1992; 19: 127–34.
  • Kornman KS, Newman MG Moore DJ, et al. The influ-ence of supragingival plaque control on clinical and microbial outcomes following the use of antibiotics for the treatment of periodontitis. J Periodontol 1994; 65: 848–54.
  • Topoll HH, Lange DE, Midler RF. Multiple periodon-tal abscesses after systemic antibiotic therapy. J Clin Periodontol 1990; 17: 268–72.
  • Fine DH. Microbial identification and antibiotic sensisensitivity testing, an aid for patients refractory to periodontal

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.